Xiaoyuan Chu

机构：Nanjing University of Chinese Medicine, Nanjing General Hospital of Nanjing Military Command, Nanjing Traditional Chinese Medicine Hospital, Nanjing Xiaozhuang University, Second Affiliated Hospital of Nanjing Medical University, Jining Medical University, Nanjing Medical University, Nanjing University · ORCID：0000-0002-7917-7874

发表论文 119 篇 · 总被引 3878 次 · h-index 40

代表论文

• Tumor organoid-immune co-culture models: exploring a new perspective of tumor immunity (2025 · Cell Death Discovery · 被引 78)
• scRNA-seq of colorectal cancer shows regional immune atlas with the function of CD20+ B cells (2024 · Cancer Letters · 被引 49)
• Quantum Dots as a Potential Multifunctional Material for the Enhancement of Clinical Diagnosis Strategies and Cancer Treatments (2024 · Nanomaterials · 被引 48)
• Tertiary lymphoid structures: new immunotherapy biomarker (2024 · Frontiers in Immunology · 被引 25)
• Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors Versus Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma with First- or Lower-Order Portal Vein Tumor Thrombosis (2024 · CardioVascular and Interventional Radiology · 被引 15)
• Transition Metal Oxide Nanomaterials: New Weapons to Boost Anti-Tumor Immunity Cycle (2024 · Nanomaterials · 被引 13)